Eruu

Ērudīre (“to remove from ignorance, to educate”) + -tiō (forming nouns from verbs). Eru.

[Eruu @Eruditio_]

@vognon_ My girl got a song for that

https://t.co/qKOacBxf7k

[Eruu @Eruditio_]

@BaseAnakFK Lebih nyantai mayor jujur…

Minor tuh 2-3 minggu tapi bimbingannya padat, tugasnya banyak, dan ngedip sebentar udah ujian akhir

[Eruu @Eruditio_]

@tanyarlfes Diucapin ultah oleh nycta gina pas masih SD kelas 5/6 :D

Gara gara follow FB jeng kelin dan beberapa kali komen di postingannya.

[Eruu @Eruditio_]

@direktoridosen Rugi berapa hari MBG ya

[Eruu @Eruditio_]

Setelah leg day dipake keliling pvj, gakebayang doms-nya gimana besok pagi 😮‍💨

[Eruu @Eruditio_]

@_AmandaBrownies @toshibatv_id Man tau gaa, rumornya kalau kaki cowo gede artinya…

[Eruu @Eruditio_]

@tanyakanrl Adaaa, terutama di lengan dan bahu. Efek nambah massa otot tapi cepet nyusut :(

[Eruu @Eruditio_]

@deronworld @FilmUpdates Not me being slow af..

[Eruu @Eruditio_]

@deronworld @FilmUpdates Girl, winning one from emilia perez is even more atrocious 😭

[Eruu @Eruditio_]

@rkitchencels Add a cube of chicken bouillon and stir that, some soft boiled egg for protein, scallion, sesame/chili oil and you got yourself a nice congee

[Sabrina Carpenter @SabrinaAnnLynn]

@WhiteHouse this video is evil and disgusting. Do not ever involve me or my music to benefit your inhumane agenda.

[Eruu @Eruditio_]

@BaseAnakFK 35% hijau, 35% kuning 30% merah.

Masyarakat di sekitar RS-ku demam 1-2 hari langsung ke igd, yang berobat ke faskes 1 dulu sampai tuntas jarang :(

[Eruu @Eruditio_]

@bebejrbl @roccoparondi Gausah sebut nama please :(

[Marianne Signoret-Bravo @DermMarianne]

Understanding the science behind sunscreens, from a dermatologist: a thread
⬇️⬇️⬇️

[RSN @rezaspn]

Official 🤝

Dokday -> Profday

[Piyush @drpiyushENT]

Here’s the ultra-concise cheat-sheet on today’s AHA/ACC High Blood Pressure Guideline (2025)—what actually changed vs 2017, and how to act on it in clinic.

Scope & status

Replaces 2017 ACC/AHA; definitions unchanged (Normal <120/80; Elevated 120–129/<80; Stage 1 130–139 or 80–89; Stage 2 ≥140 or ≥90).

Universal treatment goal

Target <130/80 mm Hg for all adults, with individualization for institutionalized, limited life expectancy, or pregnancy.

Risk tool switch

Move from Pooled Cohort Equations to PREVENT™ risk calculator to guide decisions (10- and 30-year CVD risk; integrates cardio-renal-metabolic health and social drivers). Use PREVENT to personalize when to add meds at 130/80.

When to start drug therapy

Start meds for everyone at ≥140/90.

At 130/80 to 139/89:

Start now if CVD, prior stroke, diabetes, CKD, or PREVENT ≥7.5%.

If PREVENT <7.5%: try 3–6 mo lifestyle, then start if still ≥130/80.

Combination therapy emphasis

For Stage 2 (≥140/90): initiate 2 first-line agents (ACEi/ARB, long-acting DHP-CCB, thiazide-type diuretic) preferably as a single-pill combo to improve adherence.

CKD & target organ protection

Urine albumin-to-creatinine ratio (UACR) now recommended for all at baseline (was optional). Albuminuria detection informs BP intensity and reno-protective choices.

Secondary hypertension—broader screening

Primary aldosteronism: screen more liberally (e.g., OSA, Stage 2 HTN, resistant HTN). Continue most antihypertensives (except MRA) during initial ARR screening to avoid delays.

Pregnancy & postpartum

For chronic hypertension in pregnancy, treat at ≥140/90; consider low-dose aspirin (81 mg/day) for preeclampsia risk. Ensure postpartum BP surveillance; annual BP if prior hypertensive pregnancy disorder.

Brain health

New emphasis on early treatment to reduce risk of cognitive decline/dementia; SBP goal <130 supported to protect brain health.

Resistant HTN & devices

Updated sections on resistant hypertension and renal denervation (selection, work-up, positioning in care pathway).

Out-of-office measurement

Home BP monitoring integrated into care pathways; avoid cuffless wearables for decision-making until accuracy improves.

Lifestyle remains first-line

Reinforced specifics: Na⁺ <2,300 mg/day (toward 1,500), weight loss ≥5% if overweight/obese, alcohol minimal/none, structured aerobic±resistance activity, stress-reduction.

Severe hypertension (no acute TOD)

>180/120 mm Hg without acute target-organ damage → expedited outpatient titration/initiation (not automatic admission).

Therapeutic add-ons

GLP-1 receptor agonists may be considered in overweight/obese patients to aid BP control and weight reduction—adjunct to standard classes.

Team-based care & equity

Strong push for multidisciplinary teams, single-pill combos, home BP protocols, and addressing social drivers to close control gaps.

Primary sources (today, Aug 14–15, 2025 IST): ACC press release & summary; AHA “Top Things to Know” & guideline hub (with links to Circulation/Hypertension/JACC manuscripts).

[bea ꩜ @chiirascuro]

glad to know everyone needed this just like i did, so i made lockscreens! 🤍

[Eruu @Eruditio_]

@BaseAnakFK Dokter @Marimar_Aauw mungkin bisa menjawab lebih detail 🙏🏼

[Eruu @Eruditio_]

@NATERERUN Especially whenever i’m going to all you can eat buffet

[Eruu @Eruditio_]

@BaseAnakFK Monochorionic -&gt; 1 korion/placenta
Diamniotic -&gt; 2 ketuban
Quadruplet -&gt; kembar 4